Abstract:The diterpenoid paclitaxel (Taxol ® ) is a blockbuster anticancer agent that was originally isolated from the Pacific yew ( Taxus brevifolia ) five decades ago. Despite the wealth of information gained over the years on Taxol research, there still remains supply issues to meet increasing clinical demand. Although alternative Taxol production methods have been developed, they still face several drawbacks that cause supply shortages and high production costs. It is highly desired to develop biotechnological production platforms for Taxol, however, there are still gaps in our understanding of the biosynthetic pathway, catalytic enzymes, regulatory and control mechanisms that hamper production of this critical drug by synthetic biology approaches. Over the past 5 years, significant advances were made in metabolic engineering and optimization of the Taxol pathway in different hosts, leading to accumulation of taxane intermediates. Computational and experimental approaches were leveraged to gain mechanistic insights into the catalytic cycle of pathway enzymes and guide rational protein engineering efforts to improve catalytic fitness and substrate/product specificity, especially of the cytochrome P450s (CYP450s). Notable breakthroughs were also realized in engineering the pathway in plant hosts that are more promising in addressing the challenging CYP450 chemistry. Here, we review these recent advances and in addition, we summarize recent transcriptomic data sets of Taxus species and elicited culture cells, and give a bird’s-eye view of the information that can be gleaned from these publicly available resources. Recent mining of transcriptome data sets led to discovery of two putative pathway enzymes, provided many lead candidates for the missing steps and provided new insights on the regulatory mechanisms governing Taxol biosynthesis. All these inferences are relevant to future biotechnological production of Taxol.

Research Advances on Tissue Culture and Its Product Taxol of Taxus

Morphological Characteristics, Geographical Distribution, Secondary Metabolites, and Biological Activities of Taxus

Research Progress on Production of Taxol by Plant Cell Engineering

Review on Taxus chinensis var.mairei tissue culture research

Plant Cell Culture for Production of Paclitaxel and Other Taxanes

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

[The Extraction and Separation of an Active and Available Component from Taxus Mairei].

Advances On Paclitaxel Biosynthesis In Taxus

Taxol: biosynthesis, molecular genetics, and biotechnological applications

Study on the Chemical Constituents, Pharmacological Activities, and Clinical Application of Taxus

[Callus induction, subculture, and browning inhibition of the anticancer plant Taxus media]

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

[On the Conservation and Regeneration of Taxus Resources].

A natural anticancer agent: paclitaxel

Research Progress on Seedling Propagation Techniques and Growth Influencing Factors of Taxus chinensis

Research on the Medicinal Chemistry and Pharmacology of Taxus × media

Strategies Of Improving Paclitaxel Biosynthesis In Taxus

Establishment and Assessment of Taxus media Cell Line

Biosynthesis and Regulation of Paclitaxel in Taxus

Strategies in Taxol development. A review.